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"Greatness is not in where
we stand, but in what
direction we are moving. We must sail sometimes with the
wind and sometimes against it - but sail we must, and not drift,
or lie at anchor. •
- Oliver Wendell Holmes

A Holiday Greeting
On behalf of your medical staff leadership, Drs. Rae-Grant,
Caccese and myself, I would like to extend our sincere wishes
for a warm and meaningful Holiday Season - one that
emphasizes the importance of our relationships with family and
friends. This is a valuable opportunity to strengthen the bonds
that make our society a strong fabric, and ultimately make us
strong and stable individuals. In some ways now, we
recognize the values that our country holds in common more
than those in which we agree to differ. Make this a very
special Holiday Season by reinforcing what is important to us
all.
Appreciate our freedoms. Savor and enjoy the customs, the
gatherings, the heritage and that which is our way of life at this
holiday time. Recognize and appreciate those who touch our
lives and wish them well.
We extend our greetings at this holiday time to all members of
the LVHHN extended medical family. We thank you for your
contributions and value working with you.

"America at its best matches a commitment to principle with a
concern for civility. A civil society demands from each of us
good will and respect, fair dealing and forgiveness. Civility is
not a tactic or a sentiment. It is the determined choice of trust
over cynicism, of community over chaos. And this
commitment, if we keep it, is a way to shared
accomplishment.·
- George W. Bush - Inaugural Address- 1/20/01
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First the Good News
J. Michael Eakin has been elected to the Pennsylvania
Supreme Court, Giving the Prospect of Tort Reform a
Significant Boost.
Eakin narrowly defeated fellow Superior Court Judge Kate
Ford Elliott to give Republicans control of the state's highest
court for the first time in three decades, reported the
Associated Press. Eakin was supported by physicians through
a grassroots fundraising campaign in the belief that his election
to the Pa. Supreme Court would give it a majority of strict
constructionists who would be less likely to strike down tort
reform provisions passed in the Pa. Legislature, which has
been a serious obstacle to tort reform in Pa. Eakin has also
told physicians that he is aware that the medical liability
problem is exacerbated by reimbursements that are
dramatically lower than they are in surrounding states and that
the problem is causing physicians to leave the state and to
retire early, as well as creating a significant physician
recruitment problem. (Associated Press, November 7, 2001)
We would like to thank all members of the LVH medical
staff who contributed to the campaign of Judge Mike
Eakin for Pennsylvania Supreme Court. The contest was a
victory for tort reform and a step in the right direction. He
was supported by PMS and HAP.
The judge is a self-effacing jurist with a sense of humor.
At his fundraiser, he mentioned that a State Superior
Court judge has to be careful not to take himself too
seriously. I found him refreshingly self-effacing, and very
savvy about the legal status of the Pennsylvania
malpractice crisis. It is with renewed optimism that we
now contact our state senators and representatives to
help their constituents with this nagging problem. This is
a problem that is boiling over in our sister state, West
Virginia. (See below)
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malpractice insurance crisis by the end of November, reported
the Charleston Daily Mail. West Virginia Senate Finance
Chairman Oshel Craigo said that he expects hospitals and
physicians around the state to be making similar preparations
and noted that lawmakers consider Nov. 30 to be the "dropdead" date for working out a solution to the situation, which
could include having the state extend malpractice insurance to
physicians as a stopgap measure, the Daily Mail added.
(Charleston Daily Mail, November 14, 2001)

Eighteen Delaware County Orthopedic Surgeons, the large
majority of the county's total, announced they will no
longer perform surgery or respond to trauma calls
beginning January 1 due to unaffordable medical liability
insurance.
Testifying at a Pennsylvania House Insurance Committee
meeting, the Premier Orthopaedic & Sports Medicine
Associates physicians noted that their primary malpractice
premiums would increase up to 100 percent for 2002, with total
costs projected at $130,000 per surgeon, compared with
$65,000 per surgeon just two years ago. The physicians
pointed to the increasing number and size of medical
malpractice jury awards in southeastern Pa. as a reason for
the steady climb in insurance costs. (Pennsylvania
Orthopaedic Society, 10/ 24/01.)
Although not as high in Lehigh County as in Philadelphia,
the malpractice premiums for our orthopedic colleagues
are high and have risen about 50% this year. The
manpower numbers for the high profile (high malpractice
premium) specialties, which are orthopedics,
neurosurgery, and ob-gyn, are down 10% across
Pennsylvania and down 20% in Philadelphia.

A day without sunshine is like night.
I have kleptomania, but when it gets bad, I take something for it.

Try not. There is no try. Do or do not.
-The Wisdom ofYoda
Length of Stay and at LVHHN •... Capacity Issues in
OR, ED, and on med-surg floors
West Virginia's Charleston Area Medical Center is
preparing to halt surgeries and shut down its Emergency
Room by the end of year unless lawmakers find a solution
to the state's looming malpractice crisis.
The hospital's physicians, many of whom are facing nonrenewal of their medical liability insurance, are preparing 30day notices to patients that their services will no longer be
available unless the Legislature solves West Virginia's medical

The utilization of hospital beds has been cyclic in the past. We
are now struggling with capacity constraints, which seem to be
related to availability of med-surg beds at a time when our
length of stay across the network has slowly risen. We
certainly realize that a contributing factor might be delay in
taking an in-patient to the OR for a necessary procedure.
(Continued on Page 3)
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However, the LOS has gone up for non-surgical patients as
well. When the hospital beds are full, we cannot move patients
out of the Emergency Department (which may require the ED
to go on "divert"} or out of the recovery room (which in tum
backs up patients leaving the operating rooms). We note that
both outcomes are challenges to quality patient care.
Bed management (Lisa Romano) has been alert to this issue
and monitors admissions and discharges daily in an effort to
anticipate and manage this problem.
In the past, the LVH medical staff has been responsible and
responsive to this issue. Again, we are asking for your help
and cooperation in reducing the length of LVH hospital stay.
Please wori<: with the discharge planners to arrange the best
care for your patients.
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You Say the Door is Locked?
You may have noticed that more hospital access doors now
require your photo ID badge. This is actually a continuation of
a LVHHN security policy, which has been in place for the past
several years. E. Gerald Kresge, Director of Security, has
asked all members of the medical staff to be patient with the
increased emphasis on identification of everyone on campus.
Remember that the ultimate goal is safety and security for
patients and staff alike.

Golfer. "Well, caddy, how do you like my game?"
Caddy: "Very well, Sir. But personally, I prefer golf. •

Edward M. Mullin, Jr., MD
Medical Staff President
"Yosemite Pari<: is a place of rest, a refuge ... None can escape
its charms, its natural beauty cleans and warms like a fire, and
you will be willing to stay forever in one place like a tree. •
-John Muir, 1895

New Chairperson of OB/GYN Named
Effective September 24, L. Wayne Hess, MD, was named the
new Chairperson of the Department of Obstetrics and
Gynecology.

Anesthesia Anyone?
At a recent meeting of the Department of Surgery, there was a
frank and productive discussion about the theme of OR
efficiency- start times, room turnover, avoiding delays, etc.
The issue of anesthesia providers was discussed openly by Dr.
Tom McLoughlin, and the meeting was well attended by the
surgeons and OR administrative leadership. The outcome is
an increased focus on efficiency - one that will take the
combined will of all members of the OR team and creative
incentives for each component.
Room captains? Productivity recognition and awards?
Suggestions from the OR staff about reducing room turnover
times? Room flow analysis? (sounds Urologic, I admit}
We are asking all surgeons to start their rooms on time, see
their patients (if necessary} before the case, and contribute to
OR efficiency.

The best way to forget all your troubles is to wear tight shoes.

Dr. Hess comes to Lehigh Valley Hospital and Heatth Networi<:
from the University of Missouri-Columbia Health Sciences
Center in Columbia, Missouri, where he served as Professor
and Chairman of the Department of Obstetrics and
Gynecology. His prior experience includes major leadership
positions at the University of Mississippi in Jackson, Miss., and
the United States Naval Hospitals in Portsmouth, Va., and
Bethesda, Md.
Dr. Hess received his medical degree from the Medical
College of Virginia. He completed his internship at the U.S.
Naval Hospital in Portsmouth, Va., where he also completed
his Obstetrics and Gynecology residency. He then completed
a fellowship in Maternal-Fetal Medicine at Walter Reed Army
Medical Center in Washington, D.C.
Dr. Hess is board certified in Obstetrics and Gynecology and in
Maternal-Fetal Medicine. He has had a distinguished career
as a clinician, educator, researcher, and leader. Dr. Hess has
relocated to the Lehigh Valley along with his wife, Darla, a
cardiologist and family.
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Contact Your U.S. Senators!
Urgent Action Needed to Fix Medicare
Physician Payment Update
Senator James Jeffords (1-VT) and Senator John Breaux (DLA) have offered a bill in the U.S. Senate to dramatically
improve the physician Medicare payment update for 2002.
The bill isS. 1660, the"Medicare Physician Payment Fairness
Act of 2001. • The Jeffords-Breaux bill would change the
payment update for 2002 from -5.4 percent to -0.9 percent.
Unless Congress intervenes, payments for all Medicare
services provided by all physicians and other health care
professionals will be 5.4 percent lower next year.
Please contact Pennsylvania's U.S. Senators as soon as
possible to urge them to co-sponsor and support the JeffordsBreaux "Medicare Physician Payment Fairness Act of 2001,"
s. 1660.
To read more about U.S. Senate Bill1660 and for a quick
method to send your Senator an e-mail message or to create
and print a letter, follow the "ACTION ALERT!" at
www.capwiz.com/pamedsoc <http://www.capwiz.com/pamedsoc>

Recognizing the Impaired Health Care
Professional
The impaired health care professional- physician, nurse,
ancillary provider- is one who is unable to practice his or her
profession with reasonable skill, care and diligence as well as
safety to patients because of an emotional disorder, substance
abuse or some other personal problem.
A recent study by the National Institute for Occupational Health
and Safety indicates that health care professionals may have a
higher than average risk of developing debilitating personal
problems. Research suggests that 12-14 percent of all
practicing physicians are, or will become, impaired during their
careers.
This may be due, in part, to the fact that many health care
professionals are so idealistic and perfectionistic and workaddicted in the name of healing everyone else that they don't
know how to handle their personal and emotional lives.
The impaired professional will exhibit subtle personality
changes as the problem or disorder worsens. Mood swings
may be common, ranging from irritability, outbursts of anger,
and paranoia to sudden euphoria and hyperactivity.
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In the office or hospital, the impaired professional may have
frequent schedule disruptions, behave inappropriately toward
patients, staff and colleagues, have complaints made by
patients or staff regarding his/her unusual behavior, and be
absent frequentiy due to "illness."
The impaired physician may display abnormal behavior during
rounds, give inappropriate orders and be unavailable for the
emergency room or call. His/her charting may deteriorate and
handwriting change. Allegations by staff may occur regarding
inappropriate behavior.
Regardless of profession, additional symptoms of impairment
include:
);;> Deterioration in physical appearance and
grooming
);;> Multiple physical signs and complaints
);;> Withdrawal from friends and colleagues and from
involvement in community activities
);;> Embarrassing behavior at social functions
);;> Poor judgment
);;> Inappropriate conversations with patients
);;> Neglect of commitments and responsibilities
);;> Decreasing quality of patient care
If you are concerned about a possibly impaired physician, you
are encouraged to contact the appropriate Chairperson of the
physician's department, a member of Troika, or John W. Hart,
Vice President, at (610) 402-8980~ In the case of physicians,
appropriate referrals may be made to the Physician Assistance
Program or the Physician Health Program of the Pennsylvania
Medical Society, of which the hospital and medical staff are
major contributors.
Please remember- all contacts will be kept confidential.

? ? ? Mystery Medical Staff Member ? ? ?
? Born in Wilkes-Barre, Pa.
? Received a Bachelor of Science degree at
King's College
? Received Medical degree from Jefferson
Medical College of Thomas Jefferson
University
? Surgical internship at New Rochelle Hospital
Medical Center
? Residency in Public Health at SUNY at Stony
Brook
? Joined the Medical Staff in 1997

? Drives a Green Chrysler Sebring
? Enjoys gardening
Give up? Please see Page 13 for the answer.
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How Do You Achieve Patient
Satisfaction?
Four LVHHN Physicians Check In With
Service Excellence Tips
What's the key to patient satisfaction? Four LVHHN
physicians who have received high marks from patients and
are active in service excellence initiatives had the following to
say:
Vincent R. Lucente, MD
Chief, Division of Gynecology
"We don't want to just satisfy patients, we want to wow
them-truly and honestly treat them as if they are a family
member. The doctor-patient relationship is a very special
one and the cornerstone is effective communicationcareful listening and talking in layman's terms."
Tips

>
>

>

Build a team that embraces patient satisfaction every day.
Be sincere in customer service and demonstrate that with
a smile on your face. If you're not enjoying your work,
patients will know.
Be honest in scheduling patients so you're not squeezing
people in-or you're just setting yourself up for failure.

Wayne F. McWilliams, MD
Division of Generallntemal Medicine
"Be as empathic as possible. Put yourself in their shoes
and try to understand what they're feeling. Then you can
understand their specific needs and develop a treatment
plan that makes them feel comfortable."
Tips
> Make good eye contact.
> Make sure there is a caring tone in your voice so they
know that you understand what they're going through.
> Manage your time carefully from the time you enter the
exam room. Use an internal clock to move as efficiently
through the appointment as possible.
Charles D. Peters, MD
Division of Generallntemal Medicine
"Sit and listen to your patients because they usually can
give you information that will help you understand what is
wrong with them and how to treat them. Listening is more
important than some of the technology we have, and it's
something we try to instill in our medical residency
program."
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>
>

>

Listen-really listen-to your patients.
Make a connection with your patients when you speak
with them.
Have enough administrative support in your office so you
have enough time to spend with patients.

Prodromes A. Ververeli, MD
Chief, Division of Orthopedic Surgery
"I try to relate to patients and families at their level of
understanding. This includes explaining complex medical
issues in understandable terms and analogies. The
patient and family need to understand what is going on in
order to have realistic expectations for their health care."
Tips
> Explain clinical details in simple terms.
> Make sure the patient and family understand the issues by
asking them to review what you have explained.
> Touch on a personal note at each visit. Make notes in
their chart about any upcoming anniversaries, vacations or
graduations, and then inquire about it at the next visit.

The Medical Letter
As most of you know from my previous announcement, The
Medical Letter is now on-line on the LVH Intranet. It can be
accessed by going to Clinical, then scrolling down to The
Medical Letter and double clicking.
In order to search and pull up articles from The Medical Letter.
you will need to have Adobe Acrobat installed on the hard
drive of your workstation. Not all of the hospital workstations
have Acrobat installed on their hard drives. The installation of
this software is easy and is available on the LVH network.
Follow the procedure !Jelow to install Adobe Acrobat:
If you have trouble looking up articles from The Medical Letter:
•
•
•
•
•
•
•
•
•

Click on START (bottom left of the screen)
Go to PROGRAMS - double click
See if Adobe Acrobat is there
If it is - you're all set to access The Medical Letter
If it isn't, proceed as follows:
Go to the icon on your desktop called Win Install
Interactive
Double Click on the icon
You will see a list of programs which can be installed
from the network
Click on Adobe 4. 05

(Continued on Page 6)
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•
•

Follow the instructions which will take you through the
installation process
After installation, you will need to re-boot the
computer to begin to use Acrobat to access articles
from The Medical Letter

Hopefully, this will help to solve a simple problem which has
made it difficult to get the full benefit from having The Medical
Letter "on-line".
David M. Caccese, MD

News from CAPOE Central
By now, many of you have made rounds on 6B and have seen
the implementation of computer based Medication
Administration and Vital Sign charting by the staff. The staff
has done a wonderful job of adapting to the new processes
and using the wireless devices. We have learned a
tremendous amount from the implementation on nu, and
clearly many of the processes have been improved. This
change has an impact on the physicians and physician
extenders. On 6B and nu, the most recent medication
records and vital signs are now on the computer. The
expectation is that the medical staff, housestaff, and physician
extenders will use the computer (either wireless handheld
devices or desktop computers) to view vital signs and
medications for their patients. It is not the role of the nursing
staff or the Administrative Partners to print this information out
for the rounding teams.
You may have noticed various physicians carrying wireless
devices with them in the hospital. We are piloting different
configurations (carrying cases and keyboards) with various
groups. The goal is to find the configuration that works best for
each group. The advantage of using a wireless device is that
the user remains logged in while using the device. This
eliminates the need to log in and log out on the desktop
computers on each unit during rounds. Thus, a physician can
check patient information for any patient from any location in
the hospital. The wireless device can also be used to read email and look up clinical information on the Internet.
Please use the wireless devices when you are on nu and 6B.
Given the availability of access points throughout both the
Cedar Crest &1-78 and LVH-Muhlenberg campuses, wireless
access can be realized by anyone who cares for patients at
these locations. If you or your group would like a wireless
device to use on rounds on a continuous basis, please contact
me or one of the Physician Educators- Lynn Corcoran-Stamm
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at (61 0} 402-1425, Kimbertee Szep at (61 0} 402-1431, or
Carolyn Suess at (610} 402-1416.
Donald Levick, MD, MBA
(610} 402-5100 7481 (Pager}

Tumor Boards Reinstated at LVH-M
Since the arrival of John P. Ford, MD, Associate Chief,
Division of Hematology-Medical Oncology, Tumor Boards have
been reinstated at LVH-Muhlenberg. The first of these was
held on November 7 with a review of three cases preceded by
a presentation on breast cancer by Elizabeth A. Dellers, MD,
Associate Chief, Division of Anatomic Pathology (LVH-M}. The
conference was well attended, with representatives from the
various campuses and community physicians.
Tumor Boards at LVH-Muhlenberg will continue to be held
every Wednesday, from Noon to 1p.m. in the O.R. Conference
Room on the second floor of the hospital. With Dr. Ford as
moderator, the format will be that of a "combined" tumor board
with cases not restricted to a specific organ site. Each session
begins with a short presentation and discussion of a current,
controversial topic in medicine, particularly in oncology.
Physicians wishing to participate as presenters are
encouraged to contact Maria Dreher, CTR, who coordinates
the Tumor Boards at (484) 884-5809 on Tuesdays and
Wednesdays, or at (610} 402-0518 on Mondays, Thursdays,
and Fridays. Cases for review are identified primarily by
review of pathology reports by the tumor registry. A listing of
newly identified cases (diagnosed and/or treated at LVHMuhlenberg} is compiled and three cases are selected for
presentation. Physicians wishing to have cases reviewed can
request their addition to the agenda either by calling Maria
Dreher or by impromptu requests at the meeting.
The agenda for Tumor Boards will be posted one week prior to
presentation on the Lehigh Valley Hospital TAO e-mail system.
It can be accessed by clicking first on "Bulletin Boards" and
then on "Tumor_Board_Agenda". It is flagged with an identifier
to distinguish it from Tumor Boards held at LVH-CC.
Tumor Boards are open to both clinicians and non-clinicians
alike. Nursing staff, social workers, technicians, and those
with an interest in and/or involvement in cancer care are
invited to attend. Continuing education credits will be offered
as part of attendance, and sign-in sheets will be provided.
For more information, contact Maria Dreher at one of the
numbers listed above.
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Dorothy Rider Pool Health Care Trust
Awards $3.6 Million to Lehigh Valley
Hospital and Health Network
The Trustees of the Dorothy Rider Pool Health Care Trust
have awarded seven grants totaling $3,595,000 to Lehigh
Valley Hospital and Health Network {LVHHN). The seven
grants include:

•

•
•

•

•

•

$2,700,000 over five years to the Department of Medicine
for enhancement of the medical education/residency
program. The resources will be used to help further the
growth and development of the education and research
activities within the department. Funds will also be used
to support three fellowships at LVH in the areas of
cardiology, pulmonary/critical care and hematologyoncology.
$225,000 over three years to the Department of Obstetrics
and Gynecology for discretionary use by the new chair of
the department, L. Wayne Hess, MD.
$200,000 over three years for the development of an
anticoagulation service. The anticoagulation service will
incorporate a multidisciplinary team to provide the
opportunity for improved patient outcomes through fewer
complications and enhanced patient education.
$180,000 over three years to the Department of
Emergency Medicine for the Emergency Medicine
Residency Program. The funds will be used to develop
and enhance the resources necessary to train future
emergency physicians and support continuing education
of the faculty.
$150,000 over three years to the Department of
Emergency Medicine for the sexual assault response
team {SART). The goal of the program is to develop a
consistent, comprehensive, expert, compassionate
approach to care for victims of sexual assault. The project
seeks to continue as well as enhance the existing sexual
assault forensic examiner {SAFE) program funded by Pool
Trust in 1998. The current plans include creating a Sexual
Assault Response Team to improve care by enhancing
equipment and services across the three sites - Cedar
Crest & 1-78, 17th & Chew, and LVH-Muhlenberg locations.
Services will also be provided for children under age 12.
$120,000 over three years for the Physician Leaders in
the Lehigh Valley program. The resources will be used to
provide ongoing assistance in furthering to develop
physician skills as leaders and mentors as health care
practitioners in the community. Physician Leaders in the
Lehigh Valley is a leadership development program for the
LVHHN medical staff. The program was started in 1997
and has been supported by the Pool Trust since its
inception.

..lfJ.. Volume 13, Number 12
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$20,000 to the Department of Surgery for the development
of a cardiothoracic surgery database. The resources will
help stimulate the development of a comprehensive
cardiovascular database that includes clinical,
demographic, and outcomes data for patients who have
procedures performed either in the operating room or in
the cardiac catheterization laboratory by cardiothoracic or
vascular surgeons or by medical cardiologists. The
complete cardiovascular database/registry will be
designed to integrate with and to complement the capacity
of LVH's Regional Heart Center.

Coding Tip of the Month
Diabetes Mellitus - Controlled or
Uncontrolled
It is important to let coders know whether
a diabetic patient is controlled or
uncontrolled. For example, when a
diabetic becomes hypoglycemic because
of overexercise or starvation and passes
out with a blood sugar of 40, indicate
whether you consider that uncontrolled.
When a patient is admitted with sepsis
from a urinary tract infection and a blood
sugar of 650, please document whether
you consider that uncontrolled. After
surgery, a patient taking varying doses of
insulin based on blood sugar
determination is not likely uncontrolled but
rather being controlled with sliding scale.
If the uncontrolled diabetes takes extra
work to maintain homeostasis, then
writing uncontrolled in the record will allow
the coder to pick this important
information up. Remember if it is not
written, it cannot be coded.

Radiology's Interpretation of "STAT"
STAT is interpreted as "do the study as
soon as possible" NOT "read the study as
soon as possible." Physicians who wish an
immediate wet reading should order the test
"STAT with immediate wet read."
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Congratulations!
Joel M. Glickman, DMD, Division of Endodontics, was
awarded Fellowship in the American College of Dentists on
October 12 during their Annual Meeting and Convocation in
Kansas City, Mo. The American College of Dentists was
founded in 1920 to recognize dentists who have made
significant contributions to the advancement of dentistry.

Papers, Publications and Presentations
Julie A. Dostal, MD, Vice Chairperson (LVH), Department of
Family Practice, presented on "Bridge Over Troubled Water:
Understanding the Cultural Chasm at the End of Life in
Nursing Homes" at the NAPCRG's 291h Annual Meeting which
was held in Halifax, Nova Scotia, in October. At the same
meeting, William L. Miller, MD, Chairperson, Department of
Family Practice, co-presented a full-day workshop titled
"Multimethod Approaches to Researching Practice Settings."
The workshop focused on the collection and analysis of
multimethod data designed to understand family practices from
the ground up through intensive direct observation of the
practice environment and patient care. Dr. Miller also copresented a workshop - "Literature Review as Qualitative
Research: An International, Collaborative, Participatory Search
for the Value of Family Practice." In addition, Dr. Miller coauthored two articles - "Practice Jazz: Understanding Variation
in Family Practices Using Complexity Science" and
"Understanding Practice from the Ground Up" - which were
published in The Journal of Family Practice.
Several members of the Department of Family Practice also
presented at the 20th Annual Society of Teachers of Family
Medicine Northeast Region Meeting, which was held in Mystic,
Conn., in October.
):;>

Eamon C. Armstrong, MD, gave a poster presentation
titied "Morning POEMs" Teaching Point of Care, Patient
Centered EBM." Dr. Armstrong along with Brian Stello,
MD, presented on "Evidence-Based Medicine Starts and
Ends with the Patient • Dr. Stelle also had a paper
presentation - "Just-in-Time" Clinical Practice: Resident
Use of Informatics during the Clinical Encounter."

):;>

A paper presentation was given by Dr. Dostal titled
"Screening for Health Risk Indicators: Domestic Violence
and Tobacco Use." In addition, Jennifer Neuendorff,
DO, Family Practice resident, and Dr. Dostal gave a paper
presentation titled "Bringing Health to Adolescents
Through E-COPC."

~

Sarah Nicklin, MD, gave a paper presentation "Observation of Resident Skill in Promoting the DoctorPatient Relationship."
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Mark A. Gittleman, MD, Division of General Surgery, recently
was an invited speaker at the Annual Clinical Congress of the
American College of Surgeons held October 7 to 10, in New
Orleans, La. His topics included "Image Guided Breast
Biopsy" and "lnterventional Breast Ultrasound."
Geoffrey G. Hallock, MD, Division of Plastic Surgery, recentiy
attended the Inaugural Congress of the World Society for
Reconstructive Microsurgery in Taipei, Taiwan. He presented
a paper on "Further Nomenclature Simplification of Compound
Flaps." In addition, he was a discussant on a panel describing
"Perforator Flaps." Both are unique approaches in an attempt
to improve the versatility of free tissue transfers. Of special
interest during the conference was an "on-site" visit to the
microsurgery unit in Taipei where they have a 24-bed intensive
care unit specifically for microsurgical reconstruction patients
only. This is needed to accommodate the almost 1,000 cases
of replantation and free flaps that the Chinese do on an annual
basis, and represents probably one of the largest such case
volume of any institution in the world.
Gregory R. Harper, MD, PhD, Physician in Chief, Cancer
Services, co-conducted two workshops during the annual
Keystone Breast Cancer Coalition Conference on the STAR
Breast Cancer Prevention Trial held October 18, in Harrisburg,
Pa. The STAR trial compares tamoxifen and raloxifene in the
prevention of breast cancer among high-risk, post-menopausal
women.
lndru T. Khubchandani, MD, Lester Rosen, MD, John J.
Stasik, MD, and Robert D. Riether, MD, all members of the
Division of Colon and Rectal Surgery, co-authored an article"Rectal Prolapse: A Search for the "Best Operation• - which
appeared in the July issue of The American Surgeon
(2001 ;67:622-627).
Michael K. Kim, MD, Division of Otolaryngology-Head & Neck
Surgery, gave a presentation in November at the American
Thyroid Association National Meeting held in Washington, D.C.
His talk was titied "Morbidity Following Central Compartment
Reoperation for Recurrent Thyroid Cancer.·
Vincent R. Lucente, MD, Chief, Division of Gynecology, coauthored five poster presentations at the recent American
Urogynecology Society meeting held October 25 to 28 in
Chicago, Ill. He was also the senior author on a video
presentation regarding the Laparoscopic Burch procedure,
which was presented by T. Russell Horton, MD, Chief
Resident, Department of Obstetrics and Gynecology. In
addition, he was an invited speaker for a panel discussion
regarding the Tension Free Vaginal Tape (TVT) for Female
Incontinence. Dr. Lucente presented the U.S. Experience.
While in Chicago, he was the invited visiting professor for
Grand Rounds at Northwestern University Hospital where he
presented "New Concepts in Female Lower Urinary Tract
Infections."

Medical Staff Progress Notes
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(Continued from Page 8)
Marisa A. Mastropietro, MD, Section of Pelvic Reconstructive
Surgery, had an oral presentation at the recent American
Urogynecology Society meeting titled, "Pelvic Organ Prolapse:
A Range of Normal Values."
Gary G. Nicholas, MD, Chief, Division of Vascular Surgery,
and Program Director, General Surgery Residency, was invited
to present at surgical grand rounds at Mercy Hospital in
Scranton, Pa., on September?. Dr. Nicholas' presentation"Ischemic Stroke: Current Therapy• - provided the audience
with information on the use of lytic therapy for ischemic stroke,
indicators for carotid endarterectomy, and the value of noninvasive testing with ischemic stroke treatment.
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For more information regarding Emergency Medicine Grand
Rounds, please contact Dawn Yenser in the Department of
Emergency Medicine at (484) 884-2888.

Medical Grand Rounds
Medical Grand Rounds are held every Tuesday beginning at
noon in the Auditorium of Lehigh Valley Hospital, Cedar Crest
&1-78, and via videoconference in the First Floor Conference
Room at Lehigh Valley Hospital-Muhlenberg. Topics to be
discussed in December will include:
~
~
~

December 4 - "Hometown Defense by Division of
Infectious Diseases and Infection Control"
December 11 -"Asthma and the Athlete•
December 18- "Update in Sleep Medicine"

Michael D. Pasquale, MD, Chief, Division of General Surgery
and Division of Trauma-Surgical Critical Care, co-authored an
article titled, "Multi-institutional Experience with the
Management of Superior Mesenteric Artery Injuries, • which
appeared in the October issue of The Journal of the
American College of Surgeons (2001 :193:354-366).

Department of Pediatrics

Upcoming Seminars, Conferences and
Meetings

Pediatric conferences are held every Tuesday beginning at 8
a.m., in the Auditorium of Lehigh Valley Hospital, Cedar Crest
&1-78. Topics to be discussed in December include:

Emergency Medicine Grand Rounds

~
~

Emergency Medicine Grand Rounds are held on Thursdays,
beginning at 8 a.m., at alternate locations. Topics for
December will include:

~

December 6 ·Auditorium, Cedar Crest & 1·78
~ Pediatric Case Review- St. Luke's Emergency Medicine
Residency
~ "Pulmonary Edema: From Blue as a Squid to Happy as a
Clam• and "Children are Not Just Small Adults and Other
Pediatric Myths"
~ Tintinalli Club
December 13 • 4th Floor Conference Room, LVH·M
~ M&M
~ Lower Extremity Injuries
~ Physician Wellness
~ Medical Command Tapes
December 20 • 4th Floor Conference Room, LVH·M
~ CO Poisoning
~ Domestic Violence
~ Alcohol Emergencies
~ Tintinalli Club
December27
~ No Grand Rounds - Happy Holidays!

Medical Grand Rounds will resume on January 8, 2002. For
more information, please contact Diane Biernacki in the
Department of Medicine at (610) 402-5200.

~

December 4 -"Imaging the Pediatrics Abdomen"
December 11 - "The Muscular Dystrophies -An Update"
December 18- "Case Presentation·
December 25 - No Conference

For more information, please contact Kelli Ripperger in the
Department of Pediatrics at (610) 402-2540.

General Medical Staff Meeting
A meeting of the General Medical Staff will be held on
Monday, December 10, beginning at 6 p.m., in the Auditorium
at Lehigh Valley Hospital, Cedar Crest & 1-78, and via
teleconference in the First Floor Conference Room at Lehigh
Valley Hospital-Muhlenberg. All members of the Medical Staff
are encouraged to attend.

GLVIPA Quarterly General Membership Meeting
The next quarterly general membership meeting of the Greater
Lehigh Valley Independent Practice Association will be held on
Monday, December 17, beginning at 6 p.m., in the Auditorium
of Lehigh Valley Hospital, Cedar Crest & 1-78. The meeting
agenda will include the latest updates regarding contract
negotiations, CAPOE, and a presentation on HIPAA
compliance. Reminder- in order to receive credit for your
attendance, please remember to sign in.

Medical Staff Progress Notes

December, 2001

Who's New
The Who's New section of Medical Staff Progress Notes
contains an update of new appointments, address changes,
resignations, etc. Please remember to update your directory
and rolodexes with this information.

Medical Staff
Appointments
Michael M. Badellino, MD
LVPG-Trauma Surgery
1210 S. Cedar Crest Blvd., Suite 3100
Allentown, PA 18103-6264
(610) 402-1350
Fax: (61 0) 402-1356
Department of Surgery
Division of Trauma-Surgical Critical Care/General Surgery
Site of Privileges - LVH & LVH-M
Provisional Active
Sabrina J. Logan, MD
LVH Pediatric Intensive Care
Lehigh Valley Hospital
Cedar Crest & 1-78, P.O. Box 689
Allentown, PA 18105-1556
(610) 402-7632
Fax: (610) 402-7600
Department of Pediatrics
Division of Hospital Based Pediatrics
Section of Critical Care Medicine
Site of Privileges - LVH & LVH-M
Provisional Active
Ali Salim, MD
LVPG-Trauma Surgery
1210 S. Cedar Crest Blvd., Suite 3100
Allentown, PA 18103-6264
(610) 402-1350
Fax: (610) 402-1356
Department of Surgery
Division of Trauma-Surgical Critical Care/General Surgery
Site of Privileges - LVH &LVH-M
Provisional Active
Anuja Singh, MD
Primary Care Associates in the LV, PC
1150 S. Cedar Crest Blvd., Suite 101
Allentown, PA 18103-7900
(610) 776-1603
Fax: (610) 776-6344
Department of Medicine
Division of General Internal Medicine
· Site of Privileges - LVH &LVH-M
Provisional Active
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Alex T. Thomas, MD
Base Service Unit 392
2604 Schoenersville Road
Bethlehem, PA 18017-3592
(610) 691-8028
Fax: (610) 954-0608
Department of Psychiatry
Division of Psychiatric Ambulatory Care
Site of Privileges - LVH & LVH-M
Provisional Associate

Appointment to Medical Staff Leadership Positions
L. Wayne Hess, MD
Department of Obstetrics and Gynecology
Position: Chairperson, Department of Obstetrics and
Gynecology
Thomas M. McLoughlin, Jr., MD
Department of Anesthesiology
Position: Chairperson, Department of Anesthesiology

Address Changes
Hamburg Family Practice Center
700 Hawk Ridge Drive
P.O. Box488
Hamburg, PA 19526-9219
};>- Robert B. Blauser, MD
};>- David G. Clymer, MD
};>- Paul J. Chwiecko, MD
};>- Nicholas A. DiMartino, DO
};>- E. Brian Petrasek, MD
Muhlenberg Primary Care, PC
};>- Jeffrey S. Brown, DO
};>- Robert L. Stull, DO
Health Center at Hellertown
1072 Main Street
Hellertown, PA 18055-1508
Thomas R. Lambert, DMD
2299 Brodhead Road
Suite E
Bethlehem, PA 18020-8990
(610) 868-9928
Fax: (610) 868-1289

Status Change
Suzette V. Barreto, MD
Department of Medicine
Division of General Internal Medicine
From: Associate
To: Active
Site of Privileges - LVH &LVH-M

Medical Staff Progress Notes

December, 2001

Tamar D. Earnest, MD
Department of Surgery
Division of General Surgery
From: Affiliate
To: Honorary
Robert G. Madeira, MD
Department of Medicine
Division of General Internal Medicine
From: Limited Duty
To: Active
Site of Privileges - LVH &LVH-M
Douglas C. Wiseman, DO
Department of Medicine
Division of Allergy
From: Affiliate
To: Associate
Site of Privileges - LVH-M

One- Year Leaves of Absence
David M. Flowers, MD
Department of Medicine
Division of Cardiology
From: Affiliate
To: Affiliate/LOA
· Carla M. Rossi, MD
Department of Medicine
Division of Infectious Diseases
From: Provisional Active
To: Provisional Active/LOA

Additional One-Year Leave of Absence
Robert M. Russo, MD
Department of Family Practice
Affiliate/LOA

Resignations

.l!.£ Volume 13, Number 12

Page 11

Luis I. Campos, MD
Department of Surgery
Division of General Surgery
Rene A. Chapados, MD
Department of Pediatrics
Division of Hospital Based Pediatrics
Section of Critical Care Medicine
(Effective 1/2/2002)
Edward C.H. Chen, MD
Department of Medicine
Division of Gastroenterology
William F. Dunleavy, DPM
Department of Surgery
Division of Orthopedic Surgery
Section of Podiatry
David A. Edmonds, DPM
Department of Surgery
Division of Orthopedic Surgery
Section of Podiatry
Janet E. Erickson, MD
Department of Medicine
Division of General Internal Medicine
Jerald N. Friedman, MD
Department of Surgery
Division of General Surgery
Richard M. Hughes, MD
Department of Surgery
Division of Urology
Jimmy W. Huh, MD
Department of Pediatrics
Division of Hospital Based Pediatrics
Section of Critical Care Medicine

Jeffrey B. Alpern, DO
Department of Surgery
Division of Cardia-Thoracic Surgery

Jill V. Hunter, MD
Department of Radiology-Diagnostic Medical Imaging
Division of Diagnostic Radiology
Section of Neuroradiology

Richard D. Bellah, MD
Department of Radiology-Diagnostic Medical Imaging
Division of Diagnostic Radiology

William J. Kitei, MD
Department of Surgery
Division of Ophthalmology

Larissa Bilaniuk, MD
Department of Radiology-Diagnostic Medical Imaging
Division of Diagnostic Radiology

Timothy C. Lin, DMD
Department of Dentistry
Division of Endodontics

Harry W. Buchanan IV, MD
Department of Surgery
Division of Ophthalmology

John K. Mahon, MD
Department of Medicine
Division of Neurology

Medical Staff Progress Notes

December, 2001

Richard I. Markowitz, MD
Department of Radiology-Diagnostic Medical Imaging
Division of Diagnostic Radiology
Section of Pediatric Radiology
Whitney J. McBride, MD
Department of Surgery
Division of General Surgery
Section of Pediatric Surgery
Sethuraman Muthiah, MD
Department of Medicine
Division of General Internal Medicine
John L. Potter, DMD
Department of Dentistry
Division of Periodontics
Marion B. Rose, MD
Department of Pediatrics
Division of Pediatric Subspecialties
Section of Cardiology
Eugene M. Saravitz, MD
Department of Surgery
Division of Ophthalmology
Chetan K. Shah, DO
Department of Medicine
Division of Nephrology
Bryan E. Shapiro, MD
Department of Anesthesiology
David A. Shields, MD
Department of Medicine
Division of General Internal Medicine
Lisa J. States, MD
Department of Radiology-Diagnostic Medical Imaging
Division of Diagnostic Radiology
Section of Pediatric Radiology
Terrill E. Theman, MD
Department of Surgery
Division of Cardio-Thoracic Surgery
Julio E. Torres, MD
Department of Medicine
Division of Hematology-Medical Oncology
Robert A. Zimmerman, MD
Department of Radiology-Diagnostic Medical Imaging
Division of Diagnostic Radiology
Section of Neumradiology
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Allied Health Professionals
Appointments
Kristin L Degler, PA
Physician Extender
Physician Assistant- PA
(Lehigh Valley Medical Associates- Edward J. Rosenfeld, MD)
Site of Privileges - LVH & LVH-M
Denise E. Emery
Physician Extender
Technical- Pacemaker/ICD Technician
(St. Jude Medical}
.
(Supervising Physician - Steven L. Zelenkofske, DO)
Stte of Privileges - LVH &LVH-M
Robert L. Havlicsek II
Physician Extender
Technical- Pacemaker/ICC Technician
(St. Jude Medical}
(Supervising Physician - Steven L. Zelenkofske, DO)
Site of Privileges - LVH & LVH-M
Amy J. Loutrel, PA
Physician Extender
Physician Assistant- PA
(Neurosurgical Associates of LVPG- P. Mark Li, MD)
Stte of Privileges- LVH & LVH-M
Eddie W. Malrey, PA·C
Physician Extender
Physician Assistant- PA-C
(Orthopaedic Associates of Allentown- Peter A. Keblish, MD}
Site of Privileges - LVH & LVH-M
Sandra L. Malys, RN
Physician Extender
Technical- Pacemaker/ICD Technician
(St. Jude Medical}
(Supervising Physician - Steven L. Zelenkofske, DO}
Stte of Privileges - LVH & LVH-M
Carla B. Peck
Physician Extender
Technical- Pacemaker/ICC Technician
(St. Jude Medical)
(Supervising Physician - Steven L. Zelenkofske, DO}
Stte of Privileges - LVH & LVH-M
Mark A. Sabatino
Physician Extender
Technical- Pacemaker/ICD Technician
(Medtronic lncl)
(Supervising Physician - Steven L. Zelenkofske, DO)
Site of Privileges - LVH &LVH-M
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Change of Supervising Physician
Brian J. Damweber, PA·C
Physician Extender
Physician Assistant- PA-C
From: Orthopaedic Associates of Allentown - Peter A. Keblish,
Jr., MD
To: Lehigh Valley Medical Associates- Anthony P. Buonanno,
Jr., MD
of Privileges - LVH &LVH-M

sne

Resignations
John J. Malazia, CRNA
Physician Extender
Professional- CRNA
(Allentown Anesthesia Associates Inc)
Bradley A. Nace, PA·C
Physician Extender
Physician Assistant- PA-C
(Lehigh Valley Orthopedic Group, PC)
Robert J. Peterson, PA·C
Physician Extender
Physician Assistant- PA-C
(Orthopaedic Associates of Bethlehem)

We've Moved!
On November 1, Breast Health Services at
LVH-Muhlenberg moved to a new location.
The new address is:
2597 Schoenersville Road
Suite 202
(Medical Office Building closest to
Westgate Mall)
New phone number (front desk):
(484) 884-MAMM (6266)
New phone number (file room):
(484) 884-5419
New phone number to schedule an
appointment: (610) 402-2791

OW 'UJqdiOQ IISBS
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Tbe entire staffofMedical StaffSerrices
and Physician Relations wishes you and
your family a J'ery happy and safe
hoDday season!
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MDC Update
What is MDC?

The Multidisciplinary Council (MDC) was developed in early 2001 to address systems issues in
quality improvement that involve multiple LVHHN clinical departments. The council aims to
develop and implement systems solutions that deliver health care that is: safe, effective, patientcentered, timely, efficient, and equitable. Quality assurance cases are reviewed for trends,
multi-department issues, and opportunities for improved communication.
Council members include:
~
~
~
~
~
~
~
~
~
~
~

~
~
~
~
~
~

Karen A. Bretz, MD, Vice Chairperson for Quality Assurance, Department of Anesthesiology
David M. Caccese, MD, Past President, Medical Staff, and Division of General Internal Medicine
Kim Hitchings, Manager, Professional Development
Laurence P. Karper, MD, Vice Chairperson (LVH-M), Department of Psychiatry
Michael W. Kaufmann, MD, Chairperson, Department of Psychiatry
Robert Kricun, MD, Chairperson, Department of Radiology-Diagnostic Medical Imaging
Susan Lawrence, Administrator, Case Management
Pamela F. LeDeaux, MD, Residency Program Director, Department of Family Practice
Zubina M. Mawji, MD, Division of General Internal Medicine
Francine Miranda, Risk Manager, Legal Services
Michael D. Pasquale, MD, Chief, Division of General Surgery and Division of Trauma-Surgical Critical
Care
Albert J. Peters, DO, Chief, Section of Reproductive Endocrinology & Infertility
David M. Richardson, MD, Department of Emergency Medicine
Howard D. Rosenberg, MD, Co-chief, Section of Pediatric Radiology
Paula L. Stillman, MD, MBA, Senior Medical Director, Care Management
John D. Van Brakle, MD, Chairperson, Department of Pediatrics
Michael S. Weinstock, MD, Chairperson, Department of Emergency Medicine

From time to time, the MDC will submit updates, evidence-based suggestions, and systems
changes to Medical Staff Progress Notes. Members of the Medical Staff are invited to relay
questions about MDC or suggestions for systems issues of concern to the MDC Chairperson via
email at Zubina.Mawji@lvh.com or via direct page at 610-402-5100 1456.
MDC Issue #1-Surgical patients with COPD
Recommendation #1: Order Pre-operative ABGs in selected COPD patients
Literature review:
• Post-operative pulmonary complications contributing to morbidity and mortality are at least
as common as cardiac complications, yet no clear guidelines exist for pre-operative
pulmonary evaluations.
• As the surgical incision site approaches the diaphragm, the risk of pulmonary complications
increases, but is rare following procedures outside the thorax and abdomen.
• Dyspnea at rest, hypoxemia, and in some studies elevated Pa C0 2 values, are associated
with the need for post-operative mechanical ventilation.
Therefore, pre-operative ABG values may be helpful for those patients with known or suspected
hypercapnea, and patients hypoxemic on room air, or who require the use of supplemental
home oxygen.
Sources:

Ann lnt Med 1990; 112: 793-4
NEJM 1999; 340: 937-44
NEJM 1999; 341:613-14

Authors: Karen Bretz, MD
Stephen Matchett, MD
David Caccese, MD
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The Last Word ...
Tips and Techniques for the Lastword"' User

December, 2001 -Volume 1, Issue 2

IN BOX Alerts & Reminders
by Carolyn K. Suess, R.N.
The INBOX- Alerts & Reminders
window on the Physician Base screen in
Lastword serves as a reminder to review
abnormal lab results, as well as new
ancillary results. The alerts are provided
as a courtesy to physicians practicing at
Lehigh Valley Hospital.

Abnormal Lab Results
To access abnormal lab results, click on
this alert, then click on the Select button
located at the bottom of the INBOX Alerts & Reminders window (you may

LEVAOuin
ZITHRO.Max
DIA. Mox
EPO.Gen
HYCO. 0Dn
KEFU.Fiox
YOSEMITE. Sem
DEPOPRO. Vera.
FUNTSTONE. Wilma

FENOLDO. Pam
FLO. Max

ASTRO.Boy
CARGO. Clutch

56 04
56 05
56 06
56 07

TRAINER. POE
TFWNER. POE
TFWNER. POE
TFWNER. POE

SB 09 TRAINER. POE

56 10 TFWNER. POE
56076 TFWNER. POE

New Imaging/Ancillary
and Abnormal Lab
Results

BATES. NormDn
RUBBLE. Barney
MAGIUA Gorilla

ADDAMS. Morticia
FESTER. Unde

Figure 1 - Physician Base Screen

also double-click on the alert to open it see Figure 1). The lnbox: Resolve Lab
Results screen opens, displaying
abnormal results (see Figure 2).
The window on the left side of the
screen lists the patient's name, the name
of the test, and abnormal and FYI
indicators (see heading FYI and Primary
Alerts). Click on the patient then, click
on the Select button at the bottom of the
window to choose the result you wish to
view (you may also double-click to
select the patient). Upon selecting the
patient, the Result Text window displays
the abnormal result information. Click
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completed your message, click on the
Navigate pull-down menu and select

on the Acknowledge button to indicate
you have viewed the result.

OK.
To forward the result to another
provider, click on the Forward to •••
button. The Forward Alert window
opens (see Figure 3). Right click on the
Forward to: text box to view a provider
list. You may also free text the provider
name by entering last name followed by
a comma and full first name. The result
may be forwarded to a total of four
providers.

To reassign the abnormal lab result to
another provider for sign-off, click on
the pull-down list next to the Reason for
Reassign text box and make a selection
(you may also free text your reason in
the text box). Click on the Reassign
button and the alert will be reassigned to
the provider you listed in the Forward
to: text box.
Click on the Forward on Record button
to create a record of the forward
transaction. If you prefer not to have a
record of the transaction, click on the
Forward off Record button.

If you wish to include a reason for
forwarding the result, click on the Enter
Editor button and free text a message in
the Reason for Forward window.
Adding a reason for forwarding a result
is strictly
When you have

Result
S.3
Z8.7

FYI
Indicator

column

Figure 2 - lnbox: Resolve Lab Results window

2
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Primary Alerts). Click on the patient
then click on the Select button at the
bottom of the window to choose the
result you wish to view (you may also
double-click on the patient to select it).
Upon your selection, the Result Text
window displays the ancillary/radiology
result infonnation for the patient. Click
on the Acknowledge button to indicate
you have viewed the result. This
removes the entry from your list.

Should you decide you do not want to
forward the result, click on the Cancel
button to return to the lnbox: Resolve
Lab Results screen.

New Imaging Results
Accessing new imaging results is done
in much the same way as accessing
abnormal lab results. Click on the New
imaging/ANC results ... alert, then click
on the Select button located at the
bottom of the INBOX window (you may
also double-click on the alert to select
it). The lnbox: Resolve
Ancillary/Radiology Results screen
opens, displaying new results.

As with abnormal lab results, the same
steps are used to forward imaging results
to other providers.
It is important to note, acknowledging an
INBOX result is not the same as
verifying and signing them in the
IMNET/PIM medical records system.

The left side of the screen lists the
patient's name, the name of the test, and
FYI indicators (see heading FYI and

Figure 3 - Forward Alert window
3
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FYI and Primary Alerts

To learn more about INBOX and other
Lastword features, please take a moment
and review the on-line documentation for Lastword Version 4.1. 7. Both the
CAPOE and Non-CAPOE Physician
User Guides can be found on the
LVHNN Intranet under the Resources
heading Lastword for Physicians.

As mentioned in the previous
paragraphs, FYI indicators may appear
in either the lnbox: Resolve Lab Results
or the lnbox: Resolve
Ancillary/Radiology Results screens (see
Figure 2). FYI alerts are those that had
been ordered by another physician in
your group. These alerts are sent to your
INBOX as a courtesy.

If you wish to obtain a paper copy of
either document, please contact one of
the Physician Software Educators on
staff:

Primary alerts are those that are
associated with the ordering physician.
That is to say, any lab or ancillary result
you order generates a primary alert.

Lynn Corcoran-Stamm - ext.142S
Kimberlee Szep, R.N. - ext. 1431
Carolyn K.. Suess, R.N. - ext.1416

Starting in mid-December of this year all
FYI alerts will automatically purge from
your INBOX after five days, and all
primary alerts will automatically purge
after 10 days. This does not mean the
results are purged. Lab results can be
displayed in the Viewer and Laball chart
tabs, and imaging results can be
displayed in Anc Results chart tab.

Lynn, Kimberlee and Carolyn will be
pleased to assist you.

4
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LAB-LINK
Information And Advice About Our Laboratory

NoveDJ.ber 15, 2001

Effective Decem.ber 4, 2001, at 10:00 a.m., Arterial Blood Gas testing at
Lehigh V ailey Hospital-Muhlenberg will be transferred from Respiratory
Services to Health Network Laboratories Rapid Response lab. Collection procedures
will continue to be maintained by the respiratory staff.
As with laboratory reports at all Lehigh Valley Hospital sites, results will be sent from
the laboratory computer system directly to Phamis terminals.

The following parameters will be phoned by the laboratory:
};;>Critical Values
pH:
<7.20 or >7.55
pC02:
<20mmHg or >60mEq/L
p02:
<60mmHg
TC02:
< 15mEq/L or >40mEq/L
};;>All specimens originating from the Operating Room
};;>When requested by the ordering physician
Changes in the Phamis system are being defined by Information Services and
educational inservices will be conducted by nurse educators for their respective staff.

Note:
To provide standardized reporting at ail hospital sties, the
TC02 param.eter will be added to the ABG battery at ·Cedar Crest and
17th Street sites.

Ifyou have any questions, please call Dolores Benner at 610-402-8177, Dr. Elizabeth
Dellers at 484-884-4267, or Dr. William Dupree at 610-402-8140.
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CHEMISTRY

LABORATORIES

LAB-LINK
Information And Advice About Our Laboratory

Nove~ber15,2001

When testing for Beta Human Chorionic Gonadotropin (BhCG), a spuriously
elevated result may be obtained' in those individuals with the presence of
heterophil antibodies.
Therefore, effective Dece~nber 3, 2001, the following comment will be
attached to all BhCG results:
'"~

spuriously elevated BhCG result ntay be obtained
in the presence of heterophil antibodies.
Before
ntaking a final diagnosis based on an elevated or
repetitively inconclusive BhCG result, an additional
BhCG test - with the use of heterophilic antibody
blocking ntechanism (not FDA approved) - ntay be
indicated.
The test ntust be ordered by a physician as:
"Beta hCG with heterophilic antibody blocking
ntechaniSnt" (Test Code BhCGH)."

NOTE:
This test is not replacing the basic pregnancy test (Beta Human
Chorionic Gonadotropin, BhCG). It is to be utilized as a follow-up test
when the initial results do not correlate with the clinical picture.

If you have any questions, please call our Customer Care Call Center at
610-402-8170 or Dolores Benner at 610-402-8177.

lEHJeHVAILEY
HOSPITAL

THERAPEUTICS AT A GLANCE
The following actions were taken at the October 2001 Therapeutics Committee Meeting -Joseph Ottinger, R.Ph., MS, MBA,
Janine Barnaby, R.Ph., Jenny Boucher, Pharm.D., Viraj Patel, Pharm.D., Heidi Mayville, Pharm.D.

COMPAZINEAUTOSUB
The Therapeutics committee approved a therapeutic substitution to address an on-going product shortage
ofprochlorperazine injection. The Pharmacy was authorized to change all 'prn' prochlorperazine
injection orders to promethazine injection. The following dose conversion was endorsed:
prochlorperazine doses of Smg or less will be converted to 12.5 mg of promethazine
prochlorperazine doses > than Smg but ~ 1Omg will be converted to 2Smg of promethazine.
The initial route and frequency of administration will be preserved in the conversion process, as will any
limits on the number of doses or duration of therapy specified in the original order.

FORMULARY ADDITIONS
The Therapeutics committee approved the following agents to the Formulary at its October meeting:
Hydrocodonelacetaminophen tablets- Vicodin and Vicodin ES formulations
Dorzolamide/timolol ophth soln- CoSopt ophth soln
Fluticasone/salmeterol diskus inh- Advair Diskus inh
Oxcarbazepine tablet-Trileptal
Levetiracetam tablet- Keppra
Glargine insulin- Lantus insulin

HEPARIN THERAPEUTIC RANGE CHANGES
The annual recalibration of the therapeutic heparin range has been performed by the Clinical Laboratory.
This activity is necessitated by a change in the lot number of the existing reagent. Usually the titration
curve is modified by a small degree- unlike our previous year's adjustment, that was the result of a the
purchase of a new high sensitivity reagent. The new therapeutic target, coincident with a heparin activity
level of 0.3 units/ml-0. 7 units/ml, is 69-101 seconds. ALL heparin regimens previously identified on
preprinted order sheets will be adjusted accordingly. Attached to this newsletter is the template for the
revised Heparin Order Sheet, based on the modified therapeutic range.

DROTRECOGIN ALFA
A unique 'physician order form' was approved that combined a criteria for use section along with the
medication order for this novel agent. Although not yet FDA approved, this agent appears to have
provided a significant mortality benefit in a limited study population. Therefore, the intent of the new
document was to provide the clinician with a clearly identified set of criteria (established in the
PROWESS study), where this agent was found to be beneficial. This extraordinary step was motivated
not only by the unique mechanism of action of this product, but also by its forecasted financial impact.
Although, not known at this time, the cost of a course of treatment with this agent may range from
$5,000-$20,000 per patient. A limitation on perspective prescribers and usage in selected patient-care
areas was also approved.
Attached is the template for this document, which was formulated through the combined efforts of Leslie
Baga, (Trauma Study Coordinator), Dr. Mark Cipolle, Dr. Marcelo Gareca, Dr. Stephen Matchett and Joe
Ottinger (Clinical Pharmacy).
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PROTOCOL ORDER SIIBBT :FOR Drotrecogin Alfa IXIGRI§I'M) IR SEVERE SEPSIS
RESTRICI'ED TO PHYSICIAN SPECIALITIES PRACTICING IN TilE ICU INCLUDING:
PULMONARY SPECIALISTS, INFECI'IOUS DISEASE SPECIALISTS, AND SURGEONS
CRITERIA SHEET MUST BE COMPLETED AND SENT TO PHARMACY PRIOR TO DISPENSING DRUG
PA'l'IEKT MUST SATJSFY

YES

ALL CRITERIA TO RECEIVE DROTECOGIN ALFA

J.II'O

KJunm or napected iDfection {e.c., positive blood culture, perforated vtacaa, WBC co111lt
in normally sterile body flaicl, radiosraphlc evidence of pneumonia with the production
of
t nutum.l

YES

J.II'O
!Fever ;;;o; 38 depeea C (100.4 dep-eu F) or hypothermia s 36 dep-eu C (96.8 dep-eu F)
~ C!:: 90 beats/minute except in those patients with a medical conclltion lmo'Wil to increase
the heart rate
nc co1111t ;;;o; 12,000/mm• or s 4,000/mm• or > 10% Immature neutropldla
~aplratozy rate :?! 20 breaths per minute or a PaC02 s 32mm Be or the aac of mecballical
"ntUation for an acute process

AND
ORGAN DYSFUJ.II'CTIOJI W1'1'BDI 48 HOURS DUB TO SBPSIS DESPITE ADEQUATE FLUID RESUSCITATIOJI
(One of the following)

YES

CRITBRL\
Ol'ftll
tion

J.II'O

11·

CUcllovucular

All arterial aytoUc BP s 90 mm Be OR a MAP s?Omm Be for at least 1 hour despite
adequate flaicl reaaacttation, adequate intravascular wlume atataa and/or the need for
vuopreuoza to maintain ayatoltc blood pre8II1II'C :?! 90 mm Be or MAP :?! 70 mm Be·
2 Renal
Urine o'llt1nlt < 0.5 ml/b./br for > 1hour. deaDite adeauate fluid reaaacitation
3 Resptratozy
Pa02/Fl02 ratio s 250 in the presence of other dyaflmctlonal orpu. (If patient baa
Dlleumo:aia alone the D&tient maat have a Pa02/Fi02 ratio s 200l
14 BematolocJ'
Platelet co1111t of< 80,000/ mm• or a 60% decrease in the platelet co111lt from the bJchut
lnlue recorded over the DUt 3 daya.
lletaboltc Actdoata
~
PBs 7.30 or base deftctt ;;;o; 5.0 mEq/L or a pluma lactate level> 1.5 times the upper Umtt
IDf llOrmal.

AND NONE OF THE FOLLOWING

or the followiac Contrabldlcatlona:
-Yes_ No_
-Yes_ No_
-Yes_ No_
-Yes_ No_
-Yes_ No_
-Yes_ No_
-Yes_ No_
-Yes_ No_
-Yes_ No_

Active internal bleeding
Recent (within 3 months) hemorrhagic stroke
Recent (within 2 months) intracranial or intraspinal surgery, or severe
head trauma requiring hospitalization
Any history of intracerebral arteriovenous malformation, cerebral
aneurysm, or mass lesion of the CNS
Less than 12 hours post surgery requiring general or spinal anesthesia
Trauma patients with increased risk of life-threatening bleeding
Patients with an epidural catheter
Patients with known hypersensitivity to drotrecogin alfa (activated) or
any component of the product
Patients who have via Advanced Directives indicated that therapy of
this type not be pursued.
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Other patient specific Issues THAT MAY PRECLUDE USE OF TinS AGENT, BUT THAT ARE LEFT TO
THE DISGRESSION OF THE PRESCRIBING PHYSICIAN INCLUDE:
-Initial platelet count< 20,000/mm3
-History of congenital bleecting diatheses
-GI bleeding within 6 weeks
-Less than 3 months from ischemic stroke
-Chronic renal failure requiring dialysis
-Known or suspected portosystemic hypertension, chronic jaundice, cirrhosis, or chronic ascites
-Unfractionated. heparin within the last 8 hours (<15,000 units per 24 hours permitted)
-Concurrent use of a direct thrombin inhibitor
-Use of 'Treatment dose' Low Molecular Weight Heparins (LMWH) wtmn the past 12 hours.
-ASA (>650 mgf day within the past 3 days) or NSAIDS should be discontinued
-Anti-platelet agents, thrombolytics (Within the past 3 days), or glycoprotein IIbflDa inhtbitor (within the past 7 days)
-Pregnancy and/or active breast feeding
-Known hypercoaguable condition
-Recent histmy of bone marrow or solid organ transplantaton.
-Patients with HIV (CD4 <SO)
-Patients with poorly controlled neoplasms or other end-stage processes
-Age< 18yo.
-Weight>l35 KG

MEDICATION ORDER:
Start Drotecogin alfa 24 meg/kg/hr. (patient wgt.
kg; no dosing guidelines exist for pateints > 135 kg)) ASAP. Infuse at this rate for
96 hours. If therapy is interrupted, drotrecogin should be discontinued 97 hours after therapy was initially started

Drotrecogin should be administered via a dedicated line.
Hold all other anticoagulant agents..
Hold infusion and contact physician immediately, ifarry bleeding is noted
Hold infusion 1 hour prior to arry percutaneous procedure or major surgery.
Resume infusion 1 hour qfter a percutaneous procedure and 12 hours after major surgery, unless otherwise instructed

Monitor:
CDC daily, while on drotrecogin.

PATIENT MEETS AU. PROTOCOL CRITERIA DESCRIBED ABOVE.. INITIATE THERAPY DECSCRIBED ABOVE:

Physician Signature:_ _ _ _ _ _ _ _ _ __

Date:___________________________
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DRUG ALLERGIES:

REACTIONS:

laboratory

Normal= 21-37 seconds
Equivalent therapeutic aPTI range for 0.3-0.7 units/m.l heparin level (based on anti-factor Xa
!:lll'tiivii'v'\= 69-101 seconds

Weight
ofDVT/PE
~~~L~~~~~~~~(CHECKONE)

2.

Use "Cardiae" dosing protocol (ACC/AHA Modei)..See reverse side f![ order.
Use Modified Raschke dosing protocol CPEIDVD-See reverse side f![ order.
Use Stroke/TIA dosing protocoL See~ side f![ order.
Use specific dosing regimen identified below !MJ!n describe heparin dose modifications and P'IT targets

Page25

ACC/AHA <Cardiac~ Loading dose of 60 units/kg (maximum bolus 4.000 units). followed,hy.!!!! initial infusion rate of 12
ypits/kg/br (maximum 1.000 units/hr. Adjust as indicated below.
Cardiac~ protocol

P1T <38

adjustments
Give 40 unit/kg bolus (maximum 4,000 units):increase heparin infusion rate by
100 unitslhr (<80kg) OR
200 unitslhr (~80kg)

P1T 38-55

Give 20 unit/kg bolus; increase heparin infusion rate by
100 unitslhr {all weights)

P1T 56-68

Increase heparin infusion by
100 unitslhr {all weights)

P1T 69-89

No CHANGE

PIT 90-119

Decrease heparin infusion rate by
100 unitslhr (all weights)

P1T 120-145

Decrease heparin infusion rate by
100 unitslhr (<80kg) OR
200 unitslhr (~80kg)

P1T 146-180

Stop heparin for 1 hour. Decrease heparin infusion rate by
200 unitslhr (<80kg)
300 unitslhr (~80kg)

PTI > 180

~PHYSICIAN FOR FURTilER ORDERS

Raschke CDVT/PE protocol) Loading dose of 80 units/kg, followed~ m1 initial infusion rate of ll units/kg/hr. Adjust A§ indicated
below.
Modified Raschke .!!mmrin protocol adjustments <PEIDVD
P1T < 38
80 unit/kg bolus. Increase infusion rate by
4 unitslkglhr
P1T 38-68

P1T69-101

40 units/kg bolus. Increase infusion rate by
2 unitslkg!hr
NOCHANGE

P1T 102-130

Reduce infusion rate by 1unitslkg!hr

P1T 131-155

Reduce infusion rate by 2 unitslkglhr

P1T 156-179

Hold heparin for one hour. Reduce infusion rate by 3 units/kg/hr.

P'm180

CALL PHYSICIAN FOR FURnmR ORDERS.

Stroke/TIA protocol Loading dose not recommended. Initiate infusion rate at 15 units/kg/hr. Adjust as indicated
below
Stroke/11A heparin protocol adjustments
P1T < 55
Increase infusion rate by 100 unitslhr

PIT 55-100

NO CHANGE

P1T 101-140

Decrease infusion rate by 100 unitslhr

PTI> 140

Hold he arin for 2 hours. Reduce infusion rate b 200 unitslhr
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RENAL TRANSPLANT DRUGS -DRUG INTERACTIONS
Many patients who have undergone transplantation take more than 8 different
medications daily as part of their required therapy. Renal transplant recipients are
prescribed multiple medications to sustain the transplanted organ and to treat concomitant
conditions; therefore, encountering a drug-related problem is common in this patient
population. The purpose of this article is to identify drug-related problems, specifically
interactions involving drugs commonly used in renal transplant patients. Drug
interactions, a common type of drug-related problem, are categorized as pharmacokinetic,
pharmacodynamic, or a combination of both. Pharmacokinetic drug interactions include
changes in absorption, distribution, excretion, and metabolism, whereas
pharmacodynamic drug interactions may lead to antagonistic or synergistic effects. Not
all drug interactions are undesirable; in fact, many drug interactions are used to produce
desirable effects (e.g, using a calcium channel antagonist to increase immunosuppressant
concentrations, thereby requiring a lower immunosuppressant dose).
Patients who take a drug that has a narrow therapeutic index with another drug(s) that
interferes with the pharmacokinetic properties of the object drug are at increased risk of
experiencing a drug interaction. Also, patients who take multiple medications daily or
take multiple doses of medications daily are at an increased risk for an undesirable drug
interaction. Because renal transplant patients often take immunosuppressive agents that
have narrow therapeutic indices and are subjected to multiple medications daily, these
patients are vulnerable to experiencing adverse drug events. To prevent adverse drug
interactions, an alternative therapy should be considered when possible or the dose or
schedule of the drugs should be adjusted to reduce the occurrence of an adverse effect.
Careful monitoring to prevent and detect adverse effects is an essential part of patient
care.
Pharmacokinetic Drug Interactions

A common pharmacokinetic interaction involves drugs that interfere with the absorption
of other medications. Drugs that bind (e.g, cholestyramine) potentially increase the
gastrointestinal absorption of another drug (e.g, tacrolimus). Typically administering the
agents 2-3 hours apart can prevent this interaction. Prokinetic agents
(e.g,metoclopramide) interfere with the rate of absorption. Since many transplant
patients take prokinetic agents, this may increase the bioavailability of other
medications. This is of clinical significance with immunosuppressive agents, such as
cyclosporine. If the prokinetic agent cannot be avoided, careful monitoring (e.g,
serum drug levels, clinical presentation of patient) and adjustments should be made to
prevent immunosuppressant toxicity.
CYP-450 Inhibition

Cyclosporine and tacrolimus are two of the most commonly used immunosuppressants in
renal transplant patients. Both cyclosporine and tacrolimus are metabolized
by the 3A-4 subfamily of the cytochrome P450 (CYP-450) system. This system is
responsible for the metabolism of more than 30% of drugs, and therefore many

Page27

medications that induce or inhibit the CYP-450 system are commonly administered and
may potentially cause a drug interaction. Examples of classes that inhibit the
CYP-450 system include azole antifungals, macrolide antibiotics, and calcium channel
antagonists. Examples of drugs that induce the CYP-450 system include phenytoin and
rifampin. Although it is difficult to predict the onset of the interaction on an individual
basis, the time to onset is related to the half-life of the drugs involved and the half-life of
enzyme production. Significant drug interactions of this type have been known to cause
nephrotoxicity, neurotoxicity, and graft rejection.
HMG-CoA Reductase Inhibitors
Many transplant patients have hyperlipidemia and are frequently prescribed HMG-CoA
reductase inhibitors. Cyclosporine, tacrolimus, and sirolimus may interact with HMGCoA reductase inhibitors, which could result in increased serum concentrations ofHMGCoA reductase inhibitors up to 20-fold. This interaction can result in serious injury by
causing rhabdomyolysis, acute renal failure, and even graft loss. It is recommended when
using these agents in combination with cyclosporine, tacrolimus, or sirolimus to begin
therapy with a low-dose HMG-CoA reductase inhibitor and to obtain baseline and followup creatinine phosphokinase measurements every 6 months.
P}larmacodynamic Drug Interactions
There.are numerous pharmacodynamic interactions associated with immunosuppressive
drug therapy. The concomitant use of cyclosporine or tacrolimus with aminoglycosides,
vancomycin, amphotericin B, ganciclovir, acyclovir, and nonsteroidal anti-inflammatory
medications may increase nephrotoxicity. Gingival hyperplasia is another adverse effect
associated with agents commonly used in transplant patients, such as cyclosporine,
phenytoin, and calcium channel antagonists. Other adverse drug effects seen in this
population include hyperkalemia caused by ACE inhibitors, potassium-sparing diuretics,
and cyclosporine or tacrolimus; and excessive hair growth as a result of minoxidil and
cyclosporine. Myelosuppression can result from administration of agents commonly
prescribed in the transplant population. Drugs such as ganciclovir, trimethoprimsulfam.ethoxazole, mycophenolate, allopurinol, and azathioprine can cause
myelosuppression. To avoid adverse events, selection of another drug in a different class
should be considered. However, in many situations, avoiding a medication is not
possible, and it may be necessary to use more than 1 medication associated with a
particular adverse event (e.g, gingival hyperplasia associated with the concomitant use of
phenytoin and cyclosporine). In these instances, careful attention to monitoring (e g,
adequate dental hygiene, electrolyte measurements, and complete blood count
monitoring) is necessary. Refer to Tables 1, 2, and 3 for lists of common drug
interactions with immunosuppressive agents.
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TABLE 1: Cyclosporine (CsA) and Tacrolimus Drug Interactions
DRUG
Acetazolamide
Acyclovir

MECHANISM
Decreases clearance
Crystallization in renal
tubules

EFFECTS
Increases Cs/FK level
Nephrotoxicity

Amikacin

Synergistic
nephrotoxicity

Nphrotoxicity

Amiloride

Decreases K+ secretion

Hyperkalemia

Amiodarone

Decreases clearance

Nephrotoxicity

Amlodipine

Decreases clearance

Increases CsA/FK level

Amphotericin B

Synergistic
nephrotoxicity

Nephrotoxicity

Atorvastatin

Decreases clearance of
statins

Myopathy,
rhabdomyolysis

Azithromycin

Decreases clearance

Increases CsAIFK level

Avoid in transplant
recipients
Monitor SCr and renal
funct
10% to 15% increase in
CsAIFK level; monitor
levels
Make sure patient is
adequately hydrated and
monitor electrolytes
Monitor CPK and for
the development of
rhabdomyolysis
Monitor levels

Bromocriptine

Decreases clearance

Increases CsAIFK level

Monitor levels

Calcium channel
antagonists
Carbamazepine
Carvedilol
Chloroquine
Cholestyramine

Synergistic gingival
hyperplasia
Increases clearance
Decreases clearance
Decreases clearance
Decreases absorption

Gingival hyperplasia
Decreases CsAIFK level
Increases CsAIFK level
Increases CsAIFK level
Decreases CsAIFK level

Adequate dental
hygiene
Monitor levels
Moriitor levels
Monitor levels
Separate doses by 3
hours

Cimetidine

Decreases clearance

Increases CsA/FK level

Clarithromycin
Clotrimazole
Colchicine

Decreases clea.Jllllce
Decreases clearance
Increases neurotoxicity

Co-trimoxazole

Inhibits creatinine
secretion
Inhibits clearance

Danazol
Digoxin
Diltiazem

Decreases clearance of
digoxin
Decreases clearance

Increases CsAIFK level
Increases CsAIFK level
Gastrointestinal
dysfunction and
neuromyopathy
Increases serum
creatinine
Increases CsAIFK level

COMMENTS
Monitor levels
Make sure patient is
adequately hydrated;
monitor SCr and renal
function; infuse slowly
Monitor levels; Monitor
Scr and renal function

Use another H2

antagonist agent
(ranitidine, famotidine
Monitor levels
Monitor levels

Monitor SCr and renal
function
Monitor levels

Increases digoxin level

Monitor digoxin level

Increases CsA/FK level

Monitor levels
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Enalapril

Renal dysfunction

Erythromycin
Fluconazole
Fluvoxamine
Fosinopril

Decreases clearance
Decreases clearance
Decreases clearance

Increases serum
creatinine
Increases CsA/FK level
Increases Cs:AJFK level
Increases CsA/FK level

Monitor SCr and renal
function
Monitor levels
Monitor levels
Monitor levels

Renal dysfunction

Nephrotoxicity

Monitor SCr and
renal function

Fosphenytoin
Ganciclovir

Increases clearance
Synergistic
nephrotoxicity

Decreases CsA/FK level
Nephrotoxicity

Gentamicin

Synergistic nephrotoxi

Nephrotoxicity

Grapefruit juice

Increases bioavailability

Increases CsA/FK level

Monitor levels
Make sure patient is
adequately hydrated;
monitor SCr and renal
function
Monitor levels; monitor
SCr and renal function
Monitor levels

Griseofulvin

Decreases CsAIFK level

Isoniazid
Itraconazole

Decreases clearance
Decreases clearance

Decreases CsA/FK
effectiveness
Increases CsA/FK level
Increases CsAJFK level

Ketoconazole

Decreases clearance

Increases CsA/FK level

Decreases clearance of
statins

Myopathy,
rhabdomyolysis

Methylprednisolone

Decreases clearance

Increases CsAJFK level

Methyltestosterone

Decreases cyclosporine
metabolism
Decreases gastric
emptying time

Increases CsA/FK level

Decreases clearance
Increases CsAIFK
clearance
Decreases CsAIFK
clearance
Decreases CsAIFK
clearance
Synergistic
nephrotoxicity

Increases CsA/FK level
Decreases CsA/FK level

Increase peak and AUC
by 25% to SO%;
monitor levels
Monitor levels
Monitor levels

Increases CsA/FK level

Monitor levels

Increases CsAJFK level

Monitor levels

Nephrotoxicity

Decreases CsA!FK level

CsAJFK induced
vasoconstriction is
influenced by
prostaglandin inhibition;
monitor SCr and renal
function
Monitor levels

Decreases CsA/FK level

Monitor levels

Lovastatin

Metoclopramide

Metronidazole
Nafcillin
Nefazodone
Nicardipine
NSAIDs

Octreotide
Phenobarbital

Decreases intestinal
absorption of CsAIFK
Increases CsAIFK
clearance

Increases CsA/FK level

Monitor levels
Monitor levels; decrease
dosage SO% to 85%
Monitor levels; decrease
dosage 25% to 75%
Monitor CPK and for
the development of
rhabdomyolysis
Seen at high doses of
methylprednisolone
Monitor levels
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Phenytoin
Pravastatin

Synergistic gingival
hyperplasia
Decreases clearance of
statins

Gingival hyperplasia
Myopathy,
rhabdomyolysis

Rifabutin

Increases CsAIFX
clearance

Decreases CsAIFK level

Rifampin

Increases CsAIFX
clearance
Decreases clearance of

Decreases CsA/FK level

Simvastatin

statins

Ticlopidine
Tretinoin
Triamterene
Tobramycin

Decreases K+ secretion
Decreases CsA/FK
clearance
Increases CsA/FK
clearance
Inhibits tretinoin
metabolism
Decreases K+ secretion
Synergistic
nephrotoxicity

Vaccines
Valacyclovir
Valproic acid
Vancomycin
Verapamil

Hyperkalemia
Increases CsA/FK level

Monitor CPK and for
the development of
rhabdomyolysis
Monitor levels; monitor
SCr and renal function
MonitorK+
Monitor levels

Decreases CsA/FK level

Monitor levels

Increases CsA levels

Sirolimus
Spironolacton
Terbinafine

Myopathy,
rhabdomyolysis

Hemolytic uremic
syndrome
Decreases clearance
Synergistic
nephrotoxicity
Inhibit CsAIFK
clearance

Adequate dental
hygiene
Monitor CPK and for.
the development of
rhabdomyolysis
Monitor levels; rifabutin
is a less potent hepatic
enzyme inducer than
rifampin
Monitor levels

Increases tretinoin
toxicity
Hyperkalemia
Nephrotoxicity
Decreases response to
vaccination
Renal dysfunction
Increases CsAIFK levels
Nephrotoxicity
Increases CsA/FK levels

MonitorK+
Monitor levels; monitor
SCr and renal function

Monitor SCr and renal
function
Monitor levels
Monitor SCr and renal
function
Monitor levels
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TABLE 2. Sirolimus Drug Interactions
DRUG
Amiodarone

MEcHANISM
Decreases clearance

Atorvastatin

With sirolimus and
cyclosporine

Azithromycin

Decreases clearance

Carbamazepine

Increases clearance

Cimetidine

Decreases clearance

Clarithromycin

Decreases clearance

Clotrimazole

Decreases clearance

Cyclosporine

Decreases clearance

Danazol

Decreases clearance

Diltiazem

Decreases clearance

Erythromycin

Decreases clearance

Fluconazole

Decreases clearance

Fluvastatin

Fluvoxamine

Rhabdomyolysis*
(shown with
coadministration with
sirolimus and
cyclosporine)
Decreases clearance

Grapefruit juice

Increases bioavailability

Griseofulvin

Increases clearance

Indinavir

Decreases clearance

Isoniazid

Decreases clearance

Itraconazole

Decreases clearance

Ketoconazole

Decreases clearance

Lovastatin

Rhabdomyolysis*
(shown with
coadministration with
sirolimus and
cyclosporine)

EFFECTS
Increases sirolimus
levels
Rhabdomyolysis
Increases sirolimus
levels
Decreases sirolimus
levels
Increases sirolimus
levels
Increases sirolimus
levels
Increases sirolimus
levels
Increases sirolimus and
cyclosporine levels
Increases sirolimus
levels
Increases sirolimus
levels
Increases sirolimus
levels
Increases sirolimus
levels
Monitor CPK and for
development of
rhabdomyolysis

Increasessirolimus
levels
Increases sirolimus
levels
Decreases sirolimus
levels
Increases sirolimus
levels
Increases sirolimus
levels
Increases sirolimus
levels
Increases sirolimus
levels
Monitor CPK and for
development of
rhabdomyo lysis

CO:MMENTS

Monitor CPK and for
development of
rhabdomyolysis
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Metronidazole

Decreases clearance

Nafcillin

Increases clearance

Nefazodone

Decreases clearance

Phenobarbital

Increases clearance

Phenytoin

Increases clearance

Pravastatin

Rifabutin

Rhabdomyolysis*
(shown with
coadministration with
sirolimus and
cyclosporine)
Increases clearance

Rifampin

Increases clearance

Ritonavir

Decreases clearance

Saquinavir

Decreases clearance

Sertraline

Decreases clearance

Simvastatin

Rhabdomyolysis*
(shown with
coadministration with
sirolimus and
cyclosporine)

Vaccines
Valproic acid

Decreases clearance

Verapamil

Decreases clearance

Increases sirolimus
levels
Decrea5es sirolimus
levels
Increases sirolimus
levels
Decreases sirolimus
levels
Decreases sirolimus
levels
Monitor CPK and for
development of
rhabdomyolysis

Decreases sirolimus
levels
Decreases sirolimus
levels
Increases sirolimus
levels
Increases sirolimus
Increases sirolimus
levels
Monitor CPK and for
development of
rhabdomyolysis

Decrease response to
vaccination
Increases sirolimus
levels
Increases sirolimus
levels
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TABLE 3. Azathioprine and Mycophenolate Mofetil (MMF) Drug Interactions
MECHANISM
EFFECTS
DRUG
COMMENTS
ACE inhibitors

Synergistic
myelosuppression

Anemia, neutropenia

Increase bone marrow
toxicity; monitor CBC

Acyclovir

Competition for tubular
secretions
Inhibits xanthine
oxidase

Increases toxicity

Anemia, neutropenia

Severe neutropenia

Decrease azathioprine
dose by 75%; monitor
CBC
Do not administer
together; increase bone
marrow toxicity;
monitor
MonitorCBC

Allopurinol
Cholestyramine

Decreases absorption of
MMF

Ganciclovir

Synergistic
myelosuppression
Inhibition of tubular
secretions
Increase free fraction of
mycophenolate

Anemia, neutropenia

Synergistic
myelosuppression

Anemia, neutropenia

Probenecid
Salicylates

TMP/SMX

Increase levels
Increase toxicity

Usually seen at high
doses of salicylates
TMP/SMX
MonitorCBC
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Transfusion Related Acute Lung Injury
(You are encouraged to copy and distribute this letter)

Department of Health and Human Services

Public Hearth Service
Food and Drug Administration
1401 Rockville Pike
RockVille, MD 20652·1448
August 13,2001

Dear Colleague:
This is to alert you tc the possibility that patients whc receive blood products, particular1y plasmacontaining products, may be at risk for Transfusion Related Acute lung Injury (fRAU), a serious
puJmcnary syndrome that can lead to death if not recognized and treatecl appropriately. Even small
amounts of plasma in packed red blood cells may induce TRA.U. R~niticn of symptoms and
immediate treatment are imperative.
Reports

The first TRALI fatality was reported to the Center for Biologics Evaluation and Research {CBER) in
1992. Since then, CBER has received more than 45 fatality reports af TRALI. As of FY2000 this
represented 13 percent of all transfusion fatafities. TRAI..I is thought to be the third leading cause of
transfusion related death. The majority of deaths were associated with fresh frozen plasma
transfusions; fewer were caused ey packed red blood cell tra'1sfusions and platelet transfusion&. In
mast cases, follaw..up donor antibody screens implicated donors who were multiparous females and
were positive for anti-t-!LA or anti-granulOCyte antibodies. Non-fatal TRAU events reported by licensed
blood estabfiShments through Med Watch or as Biological Product Deviation reports are also on the
inaease. There have been 26 such reports since 1999. This finding may be attnbutable to better
recognition and reporting of events. Because af misdiagnosis andJor underreoorting, the full scope of
TRALI is not known.
·
Description and Cause of Problem

TRAL.I is a well-characterized clinical constellation of syml)toms including dyspnea, hypoten$iCn. and
fever. The radiological picture is of bilateral pulmonary

infiltrates Wltl'lout evidence of cardiac

compromise or fluid overload. Symptoms tyl)ieally begin 1·2 hours after transfusion and are fully
manifest within 1..e hours. Products typically implicated in TRAlf are whole blood, packed red blood
ce!Js, fresh frozen plasma, cryoprecipitate. platelet concentrates. apheresis platelets, and rarely IGIV , .
The etioJogy of TRAU may be attributable to the prnence of aflti..HLA and/ or anti-granulocyte

antibodies in the plasma cf multiparous females or donors who have received previous transfusion&.
TRAU recipients have no specific demographics such as age, gender, or previous transfusion hiStory.
Some investigators have hypothesized that TRAU is the result of two independent insults: patient
clinical status and anti-white cell antibodies. Transfusion recipients who developTRALI '/rei have had a
predisposing event such as surgery, active infection, mas&ive transfusion, or cytokine therapy that
causes activation of the pulmonary endothelium and priming of the recipient's white blood cells 2.
Although TRALI does not always occur thro:JP.r• trar.sfusions from donors with anti-HLA or anti3
granulocyte antibodies. one or both ofthese antibody types have been found in 89% ofTRALI cases.

'

1 Rizk A, Gorson K, Kenny L, and 'Weinstein R: Transfusion-related acute lung injury after the
infusion of IVIG. Trandl$ion 2001; 41:264-268.
2 Popovsky,MA. ChapUn, HC, and Moore, SB. Transfusion-relat9cllung injury: a negleCted
serious compticaticn of hemotherapy. Transfusion 1992; 32:589-592.
3 Silliman,C Transfusion-related acute lung injury. Transfusion 1999; 13:177-186.

DiagnosiS and Treatment

It appears that unlike allergic or anaphylactic immune-mediated transfusion reactions, antibodies
impDcated in TRAJ..l are usually of donor origin. Once transferred to the recipient, these antioodies may
cause complement activation resulting in neutrophilic influx into 1he lungs and damage to the
pulmonary rricrovasculature. The clinical result may be subtle or significant_ In either case, there is
typically a marl<ed hypoxemia, hypotension. fever, and severe bUateral pulmonary edema. Respiratcry
support shoUld be as intensive as dictated by the clinical picture. Diuretics play no role in TRALI as the
underlying pathology invclves micrQvascular injury, rather ihan fluid overload.

Recommendations
1. Be alert that any respiratory distress occurring during or following blood or blood component(s)
transfusion could potentially be TRAU. Discontinue the transfusion immediately. Begin oxygen
and supportive therapy.
2. Notify the Blood Center that supplied the blood component and return remaining product to be
tested fer anti·HLA and/or anti-granulocyte antibodies in the donor.

3. Fatalities from TRALI should be reported tD CSER in accordance With 21CFR 606.170(b}. FDA
encourages voluntary reporting ofTRALI as a serious adverse reaction to transfusions. Reports
can be filed via MecMBtch by phone at 1-eQO.FOA-1088, by fax at 1..SOO-FDA-0178, by us mail
at Med\IVatch, HF-2, 5600 F'IShers Lane, Rockville, MD 20852, or by email at
httc;/Jwww.fda.ge~~r:madwatch.

For More lnfonnation
lf you have Questions regarding this alert, please contact Or. Leslie Holness, Center for Biologics
Evaluaticn and Research, FDA, 1401 Rockville Pike, Mail Step HFM·375, Rockville, MD 20852.:1448,
by fait at 301-827·3:34, or by e-man at !:I.QLNESS@cber. fda.gov.

Sincerely,
Kathryn C. Zoon, Ph.D.

Director

Center for Biologics Evaluation and Research
Food and Drug Administration
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NEWS FROM THE LffiRARY.

Computer-Based Training (CBT):

OVID Instruction
Contact Barb Iobst at 610-402-8408 to arrange for instruction
in the use of OVID's MEDLINE and its other databases.
Announcing New Online Full-text Products.
Several new online full-text products are available from any
workstation that has access to the LVHHN INTRANET home
page. When at the home page, select "*Departments*" then
"Clinical," and pick one of the following from the list:

Computer Based Training (CBT) programs are available for
LVHHN staff. Topics covered by the CBT programs include:
Access 2.0
Power-Point 4.0
Windows NT 4
Word 97
Excel 97
Access 97
PowerPoint 97
Lotus 1-2-3 Millennium
WordPerfect 8
E-mail GUI
PHAMIS LastWord Inquiry Only commands
'-

"The Medical Letter" - Information regarding anthrax was
available in the last two issues.
"Books@ Ovid" is a new entry in the list of databases
available to LVHHN from "Ovid Online:"
You can access the following Lippincott books using "Ovid
Online":
Scott: "Danforth's Obstetrics and Gynecology," 8th ed. 1999.
Sadock: "Kaplan's & Sadock's Comprehensive Textbook of
Psychiatry," 7th ed. 2000.
Goroll:"Primary Care Medicine," 4th ed. 2000.
Hume:"Kelley's Textbook oflnternal Medicine," 4th ed. 2000.
_ _: "Drug Facts & Comparison,"- Pocket Version. 2001.
While in "Ovid Online," don't forget to try LVHHN's free trial
subscription to "Evidence Based Medicine."

CBT programs replace the instructor-led classes previously
held at Lehigh Valley Hospital. A proctor will be in the room
with the learner while he/she takes the CBT, but the learner
will control the pace and objectives of the learning.
Computer Based Training takes place in Suite 401 of the
John & Dorothy Morgan Cancer Center (the computer
training room) and in the Muhlenberg Hospital Center
computer training room (off the front lobby). The schedule
ofupcoming dates is as follows:

CBT sessions for JDMCC, suite 401 are as follows:
December 18, noon - 4pm
January 8, Sam- noon
February 12, noon- 4pm
March 26, Sam - noon
April 23, Sam- noon
Sessions at MHC, I.S. Training room are as follows:
March 5, noon- 4pm
May 14, noon-4pm

New Library Publications.

Twelve slots are available for each session.

CC & 1-78 Site
''Pediatric and Adolescent Gynecology," 2nd edition.
"Multiple Organ Failure: Pathophysiology, Prevention, and
Therapy"
"Rosen's Breast Pathology," 2nd edition.

To register, please contact Suzanne Rice via e-mail or at 610402-2475 with the following:
date of session
second date choice
department
phone number
You will receive an e-mail confuming your choice within two
business days. If you have any questions, please contact Craig
Koller at 610-402-2413 or through e-mail.

1
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Host, Vermont Public Television, Burlington, VT

Center for Educational De11elopment and Support
Presents the following Educational Activities:
ETHICAL ISSUES IN PAIN MANAGEMENT
A Satellite Teleconference from The University of Vermont
Thursday, December 6, 2001
1:30-3:30 PM
Classroom #2- Cedar Crest & 1-78
VTC Room - 17th & Chew Sts.

On a daily basis, health care professionals face pain management dilemmas
that involve serious ethical considerations. The questions surrounding this
issue are complex & often the answers have been hard to find.
Using an interdisciplinary approach, this compelling program analyzes the
real-life ethical challenges that providers confront in the course of doing
what's best for their patients.
This two-hour program offers a forum to explore the ethical questions
surrounding pain management and provides a framework for tackling the most
common dilemmas faced in everyday practice. Learn the concepts necessary
to help you address critical medical ethical issues.
Program Overview:
Under Treatment of Pain
•
Provider bias and beliefs: barriers & constraints
Fear of criminal prosecution
•
Misconceptions concerning addiction & tolerance
•
Drug Addiction and Diversion
•
Definition of addiction & pseudo-addiction
•
Dependence & tolerance issues
•
Drug diversion & its impact on pain treatment practices
Ethical Principles and Decision Making
•
Developing a knowledge base & self awareness
•
Applying ethical principles & pain management knowledge
•
Generating solutions in consultation with the patient
Ethical Obligations ofProviders
•
Accountability for pain relief
•
Pain prevention, assessment & treatment
•
Assuring institutional & clinical standards

Presenters:
Benjamin W. Moulton, J.D., M.P.H.
Executive Director, American Society of Law,
Medicine and Ethics, Boston, MA

Continuing Education Credits:
The University of Vermont programs are designed to meet the continuing
education needs of health care professionals. Nursing Contact Hours,
Continuing Medical Education Credits & Nursing Home Administration
Contact Hours are available to this teleconference. Please note, continuing
education credit is available to participants viewing the event live via satellite
only. Credit is not available for viewing the videotape.
To register:
Advanced registration is required since seating is limited.

Using E-mail:
--Please access the Bulletin Board entitled Forms_Nursing.
--Select the Cont. Education Registration Form.
-Right click on the form and choose "Use Form".
- Complete all areas (refer to "How To Register" for more help on using
forms).
- Indicate which site you will be attending.
-- Use the comments section to provide us with any additional information
that may be useful.
-We will be unable to process incomplete registrations.

Using Phone or FIIX:
--Please either can (610-402-2277) or fax (610-402-2203) the following
information: name, hospital affiliation, position, mailing address, social
security#, daytime phone#, and day attending. We will be unable to process
incomplete registrations.

PRECEPTOR PROGRAM
Educational program for RN's who will be assigned responsibility to orient
new staff to their clinical unit.
Date
Mon., December 10,2001

Time
0745-1630

Location
Classroom #8-JDMCC

REGISTRATION:

Using e-maiL..
-Please access the Bunetin Board entitled Forms_Nursing.
-Select the Cont. Education Registration Form.
-Right click on the form and choose "Use Form".
-Complete an areas (refer to "How To Register" for more help on using
forms).
-- Indicate which day you will be attending.
- Use the comments section to provide us with any additional information
that may be useful.
-We will be unable to process incomplete registrations.

For stlljJwithout e-mail access.••

Myra J. Christopher
President and CEO, Midwest Bioethics Center,
Kansas City, MO

-Please either call (610-402-2277) or fax (610-402-2203) the following
information: name, hospital affiliation, position, mailing address, social
security#, daytime phone#, and day attending. We will be unable to process
incomplete registrations.

Robert Orr, MD
Director of Clinical Ethics, Fletcher Allen Health
Care, Burlington, VT

If you have any questions, please call the Center for Education at 610-4022277.

Rodney Bolejack, D.Min.
Chaplain, VistaCare Family Hospice, Temple, TX
John Coleman, MA, MS
Drug Enforcement Administration, Assistant
Administrator (Retired), Clifton, VA
Moderator: Portland Helmich

2

Any questions, concerns or comments on articles from CEDS, please contact
Bonnie Schoeneberger 610-402-2584
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December
Sun

Mon

Tue

Wed

Thu

Fri

Sat

1

2

I

3

12 noon Colon/Rectal TB
JDMCCCRI

10

9

4
7am Family Practice GRJDMCC IA/B
7am Surgical GR CC-Aud
Sam Pediatric GR CC-Aud
12 noon Medical GR CCAud

11
7am Surgical GR CC-Aud
Bam Pediatric GR CC-Aud
12 noon Medical GR CCAud

16

I

17

12 noon Colon/Rectal TB
JDMCCCRI

23

24

18
7am Surgical GR CC-Aud
Sam Pediatric GR CC-Aud
12 noon Medical GR CCAud

25

5
12 noon MHC TB OR
Conf. Rm

12
12 noon MHC TB OR
Conf. Rm

19
12 noon MHC TB OR
Conf.Rm

26
12 noon MHC TB OR
Conf. Rm

6
Bam Emergency Medicine
GR LVH-CC Aud
12 noon Combined TB
JDMCCCRI

7

8

7am GYN GR CC CRI
II am Neurology Conf CC
Crt
12 noon Breast TB JDMCC
CRI

13

14

Bam Emergency Medicine
GR LVHM-4'h Fl ConfRm
12 noon GI TB JDMCC
CRI

7am OBGYN GR CC CRI
II am Neurology Conf CC
Crt
12 noon Breast TB JDMCC
CRl

20

21

Bam Emergency Medicine
GR LVHM 41k Fl ConfRm
12 noon ENTTB JDMCC
CRt

7am OBGYN GR CC CRI
12 noon Breast TB JDMCC
CRt

27
12 noon Combined TB
JDMCCCRI

I

15

I 22

28 I 29
7am OBGYN GR CC CRI
12 noon Breast TB JDMCC
CRI
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